153 related articles for article (PubMed ID: 11943414)
1. Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers.
Ritzel U; Leonhardt U; Näther M; Schäfer G; Armstrong VW; Ramadori G
J Hepatol; 2002 Apr; 36(4):454-8. PubMed ID: 11943414
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis.
Cash WJ; O'Neill S; O'Donnell ME; McCance DR; Young IS; McEneny J; McDougall NI; Callender ME
Liver Int; 2013 Sep; 33(8):1166-74. PubMed ID: 23672463
[TBL] [Abstract][Full Text] [Related]
3. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
[TBL] [Abstract][Full Text] [Related]
4. The effects of lipid-lowering agents on acute renal allograft rejection.
Kasiske BL; Heim-Duthoy KL; Singer GG; Watschinger B; Germain MJ; Bastani B
Transplantation; 2001 Jul; 72(2):223-7. PubMed ID: 11477342
[TBL] [Abstract][Full Text] [Related]
5. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
Isles CG; Paterson JR
QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
[TBL] [Abstract][Full Text] [Related]
6. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus.
Ichimaru N; Takahara S; Kokado Y; Wang JD; Hatori M; Kameoka H; Inoue T; Okuyama A
Atherosclerosis; 2001 Oct; 158(2):417-23. PubMed ID: 11583721
[TBL] [Abstract][Full Text] [Related]
7. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment.
Fiegenbaum M; da Silveira FR; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
Clin Pharmacol Ther; 2005 Nov; 78(5):551-8. PubMed ID: 16321621
[TBL] [Abstract][Full Text] [Related]
8. Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia.
Tazuma S; Yamashita G; Ochi H; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Kajiyama G
Clin Ther; 1998; 20(3):477-85. PubMed ID: 9663363
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects.
Ntanios FY; Jones PJ; Frohlich JJ
Metabolism; 1999 Jan; 48(1):68-73. PubMed ID: 9920147
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.
Murdock DK; Murdock AK; Murdock RW; Olson KJ; Frane AM; Kersten ME; Joyce DM; Gantner SE
Am Heart J; 1999 Jul; 138(1 Pt 1):151-5. PubMed ID: 10385779
[TBL] [Abstract][Full Text] [Related]
11. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.
De Caterina R; Cipollone F; Filardo FP; Zimarino M; Bernini W; Lazzerini G; Bucciarelli T; Falco A; Marchesani P; Muraro R; Mezzetti A; Ciabattoni G
Circulation; 2002 Nov; 106(20):2543-9. PubMed ID: 12427649
[TBL] [Abstract][Full Text] [Related]
14. Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.
Baldissera MD; Souza CF; Grando TH; Doleski PH; Boligon AA; Stefani LM; Monteiro SG
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):215-223. PubMed ID: 27913825
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
Karas RH; Kashyap ML; Knopp RH; Keller LH; Bajorunas DR; Davidson MH
Am J Cardiovasc Drugs; 2008; 8(2):69-81. PubMed ID: 18422390
[TBL] [Abstract][Full Text] [Related]
16. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].
Tvorogova MG; Susekov AV; Semenova OA; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(12):8-13. PubMed ID: 10067240
[TBL] [Abstract][Full Text] [Related]
17. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
18. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging.
Corti R; Fuster V; Fayad ZA; Worthley SG; Helft G; Smith D; Weinberger J; Wentzel J; Mizsei G; Mercuri M; Badimon JJ
Circulation; 2002 Dec; 106(23):2884-7. PubMed ID: 12460866
[TBL] [Abstract][Full Text] [Related]
19. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
Conde K; Pineda G; Newton RS; Fernandez ML
Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
[TBL] [Abstract][Full Text] [Related]
20. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
